Ibuprofen Use During Pregnancy
Ibuprofen can be prescribed during the first and second trimesters of pregnancy at the lowest effective dose for short durations (7-10 days), but must be discontinued after gestational week 28 due to significant fetal risks including premature closure of the ductus arteriosus and oligohydramnios. 1
Safety by Trimester
First Trimester (Weeks 0-13)
- Early pregnancy exposure to ibuprofen shows no evidence of increased risk of miscarriage or teratogenicity when used appropriately 1
- Ibuprofen has the most reassuring safety data among NSAIDs, followed by diclofenac 1
- A large cohort study of 1,117 women exposed to ibuprofen in the first trimester found no significantly increased risk of major birth defects (4.8% vs. 4.1% in controls) or distinct pattern of malformations 2
- However, women actively trying to conceive should avoid NSAIDs as they can interfere with ovulation by inducing luteinized unruptured follicle (LUF) syndrome, potentially reducing fertility 1
Second Trimester (Weeks 14-28)
- Short-term use (7-10 days) at the lowest effective dose does not appear to pose substantial fetal risks 1
- Ibuprofen may be considered during this period when needed to control disease activity in conditions like pericarditis or inflammatory arthritis 1
- The FDA label specifies that if NSAID treatment extends beyond 48 hours after 20 weeks gestation, ultrasound monitoring for oligohydramnios should be considered 3
- All NSAIDs must be discontinued by gestational week 28 (end of second trimester) 1
Third Trimester (Week 29 onwards)
- Ibuprofen is contraindicated after gestational week 28-30 due to severe fetal risks 1, 3
- Specific fetal complications include:
Clinical Decision-Making Algorithm
When pain management is needed during pregnancy:
First-line: Use acetaminophen at the lowest effective dose for the shortest duration 5
If acetaminophen is insufficient in first/second trimester:
For chronic inflammatory conditions requiring ongoing treatment:
After gestational week 28:
Important Caveats and Pitfalls
Timing Considerations
- The critical cutoff is gestational week 28, not the traditional "third trimester" designation, as fetal sensitivity to NSAID-related risks increases significantly after this point 1
- The ESC guidelines suggest an even more conservative approach, recommending discontinuation by gestational week 20 for most NSAIDs (except low-dose aspirin ≤100mg/day) and mandatory discontinuation by week 32 1
Fertility Concerns
- Women with difficulty conceiving should discontinue NSAIDs entirely, as continuous periovulatory exposure can prevent ovulation 1
- If NSAIDs are necessary, use intermittently rather than continuously around the time of ovulation 1
Drug Selection
- Prefer nonselective NSAIDs with short half-lives (like ibuprofen) over COX-2 selective inhibitors, which have limited safety data 1
- Avoid indomethacin despite its historical use as a tocolytic, as it has greater risks than ibuprofen 1
Monitoring Requirements
- If ibuprofen use extends beyond 48 hours after 20 weeks gestation, consider ultrasound monitoring for oligohydramnios 3
- If inadvertent third-trimester exposure occurs, immediate discontinuation and fetal assessment for ductal constriction and oligohydramnios is necessary 6